Karin McIntosh
4 years ago
By Yvie
Share on
Session – Implementing change control in a newly commericalised company Karin McIntosh is a Regulatory CMC Executive Director for Stemline Therapeutics Inc. with a Master of Pharmacy and 15 years of pharmaceutical industry experience including 12 years within Regulatory Chemistry, Manufacturing & Controls. Proven track record of high-quality submissions for EU, US and global markets covering pre-approval (clinical), initial registrations and post-marketing for small molecules, large molecules (biologics) and combination products.
More news
